title: Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.
abstract: Left ventricular (LV) pressure (PO) or volume (VO) overload is accompanied by myocardial remodeling, but mechanisms that contribute to this progressive remodeling process remain unclear. The matrix metalloproteinases (MMPs) contribute to tissue remodeling in a number of disease states. This study tested the hypothesis that increased MMP expression and activity occur after the induction of an LV overload, which is accompanied by a loss of endogenous MMP inhibitory control. LV MMP zymographic activity and species abundance were measured in dogs under the following conditions: acute PO induced by ascending aortic balloon inflation (6 h, n = 9), prolonged PO by aortic banding (10 days, n = 5), acute VO through mitral regurgitation secondary to chordal rupture (6 h, n = 6), prolonged VO due to mitral regurgitation (14 days, n = 7), and sham controls (n = 11). MMP zymographic activity in the 92-kDa region, indicative of MMP-9 activity, increased over threefold in acute PO and VO and fell to control levels in prolonged PO and VO. The MMP-9 activity-to-abundance ratio increased by over fourfold with acute VO and twofold in acute PO, suggesting a loss of inhibitory control. Endogenous MMP inhibitor content was unchanged with either PO or VO. Interstitial collagenase (MMP-1) content decreased by 50% with acute VO but not with acute PO. Stromelysin (MMP-3) levels increased by 40% with acute VO and increased by 80% with prolonged PO. Although changes in LV myocardial MMP activity and inhibitory control occurred in both acute and prolonged PO and VO states, these changes were not identical. These results suggest that the type of overload stimulus may selectively influence myocardial MMP activity and expression, which in turn would affect the overall LV myocardial remodeling process in LV overload.
authors.affiliation: Division of Cardiothoracic Surgery and Cardiology, Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29425, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Nagatomo
authors.forename: B A
authors.initials: BA
authors.lastname: Carabello
authors.forename: M L
authors.initials: ML
authors.lastname: Coker
authors.forename: P J
authors.initials: PJ
authors.lastname: McDermott
authors.forename: S
authors.initials: S
authors.lastname: Nemoto
authors.forename: M
authors.initials: M
authors.lastname: Hamawaki
authors.forename: F G
authors.initials: FG
authors.lastname: Spinale
mesh_terms: D000818:Animals; D004285:Dogs; D006352:Heart Ventricles; D006940:Hyperemia / Q000378:metabolism*; D006973:Hypertension / Q000378:metabolism*; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D013314:Stress, Mechanical; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism; D016277:Ventricular Function, Left
chemical_list: D019715:Tissue Inhibitor of Metalloproteinase-1; D008666:Metalloendopeptidases